Maximum quantity allowed is 999
请选择数量
CAS RN: 58-46-8 | 产品编码: T2839
Tetrabenazine
×
![]()
×
| 产品编码 | T2839 |
| 纯度/分析方法 | >99.0%(T)(HPLC) |
| 分子式/分子量 | C__1__9H__2__7NO__3 = 317.43 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 冷藏 (0-10°C) |
| 储存在惰性气体下 | 存放于惰性气体之中 |
| 应避免的情况 | 空气,加热 |
| 包装和容器 | 200MG-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 58-46-8 |
| Reaxys-RN | 40090 |
| PubChem物质ID | 160871211 |
| Merck Index (14) | 9182 |
技术规格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 99.0 area% |
| Purity(Nonaqueous Titration) | min. 99.0 % |
| Melting point | 124.0 to 130.0 °C |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 127 °C |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H302 : Harmful if swallowed. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相关法规
| RTECS# | DK2275000 |
运输信息
| HS编码* | 2933.99-000 |
应用
Tetrabenazine: A Reversible Inhibitor of the Vesicular Monoamine Transporter Type 2 (VMAT2)
Tetrabenazine is a reversible selective inhibitor of the vesicular monoamine transporter type 2 (VMAT2) resulting in decreased uptake of monoamines into synaptic vesicles, breaking down of monoamines by monoamine oxidase (MAO) and depletion of monoamine stores. Therefore, tetrabenazine works as a depletor of monoamines (such as dopamine [A0305], serotonin [S0370], norepinephrine [A0906], and histamine [H0146]) from nerve terminals. Tetrabenazine is metabolitzed by carbonyl reductase to the initial active metabolite dihydrotetrabenazine (HTBZ), a mixture of α-HTBZ and β-HTBZ. HTBZ also inhibits the VMAT2. Although the precise mechanism is unknown, tetrabenazine is effective in treating chorea (Huntington’s disease). In addition, reserpine [R0007] inhibits VMAT. (The product is for research purpose only.)
References
- Tetrabenazine-induced depletion of brain monoamines: Characterization and interaction with selected antidepressants
- Pharmacokinetics of tetrabenazine and its major metabolite in man and rat
- Absolute configuration of (+)-α-dihydrotetrabenazine, an active metabolite of tetrabenazine
- Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A
- Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature
- Development and validation of stability indicating RP-HPLC method for the estimation of tetrabenazine in bulk and pharmaceutical dosage form
参考文献
文章/手册
TCIMail
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。